Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)

This study is testing a full-spectrum cannabis extract for people with tuberous sclerosis complex (TSC) — a genetic condition that causes non-cancerous tumors to grow throughout the body, often leading to severe, drug-resistant epilepsy (seizures that don't respond to medication). **You may be eligible if...** - You are between 2 and 65 years old - You have a confirmed diagnosis of TSC - You have epilepsy that has not responded to at least 2 different anti-seizure medications, ketogenic diet, vagal nerve stimulator, or surgery - You have had at least 4 seizures with visible symptoms in the 4 weeks before the study starts - Your current seizure medications and other treatments have been stable for at least 4 weeks **You may NOT be eligible if...** - You have a history of severe psychiatric disorders like psychosis - Your seizures are well controlled with current treatments - You have significant liver or kidney problems Talk to your doctor to see if this trial is right for you.